Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options ... of GLP-1 medications remains prohibitively high for many. The move positions Lilly as a ...

Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage ...

Eli Lilly and Company has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self ... of Zepbound in response to high demand and offers a more affordable ...

Six months after Eli Lilly began selling discounted vials of its blockbuster weight loss drug Zepbound, the company expanded the offering Feb. 25 to include cheaper, high-dose Zepbound vials.

MORE: Apple juice sold at Walmart recalled due to arsenic levels "These new vials not only help us meet the high demand ... The cheaper low-dose Zepbound vials would expand availability to ...

More doses of Novo Nordisk’s popular weight loss drug Wegovy are back in stock in the U.S. after years of shortages and just days after all doses of Eli Lilly’s rival injection Zepbound became ...

and Zepbound are now available, per the FDA’s drug shortage list. Starter doses of the weight loss drug Wegovy remain in limited supply. Despite increased availability, high costs still prevent ...